Dr. Jenkins, an insightful contributor in internal medicine, dives into groundbreaking studies that could change clinical practice. He discusses the best anticoagulants for patients with cirrhosis and atrial fibrillation, pondering the roles of apixaban and rivaroxaban. The conversation pivots to the efficacy of beta blockers post-myocardial infarction, questioning traditional protocols. They also explore antibiotic delivery methods in sepsis and compare cefepime against piperacillin-tazobactam, raising concerns about efficacy and safety in treatment.
